Rochester, NYNCT06911931Now EnrollingIRB Ready

Schizophrenia Disorders Clinical Trial in Rochester, NY

Access cutting-edge schizophrenia disorders treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.

Sponsored by University of Rochester

Quick Self-Assessment

See if you qualify for this Rochester location

Preparing your pre-screening questions…

Expert Care in Rochester

Access schizophrenia disorders specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related schizophrenia disorders treatment provided free

Apply for This Rochester Location

Check if you qualify for this schizophrenia disorders clinical trial in Rochester, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rochester

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rochester site if eligible
  4. 4Begin participation

About This Schizophrenia Disorders Study in Rochester

This study aims to identify novel markers of psychosis using electroencephalography (EEG).

Sponsor: University of Rochester

Who Can Participate

Inclusion Criteria

All Subjects
20/32 visual acuity or better (using in-house optical correction, if necessary)
An ability to speak English well enough to complete study assessments and to consent to the study
Subjects with Schizophrenia-Spectrum Disorder
Meets DSM-5 diagnostic criteria for schizophrenia, schizoaffective disorder, or schizophreniform disorder as confirmed by the Structured Interview for DSM-5 (SCID-5).
Subjects with Bipolar Disorder
Meets DSM-5 diagnostic criteria for bipolar disorder (type I, II, or unspecified) as confirmed by the Structured Interview for DSM-5 (SCID-5).

Exclusion Criteria

All subjects
Presence of characteristics that could impair one's ability to comprehend the nature of the study, provide informed consent, or understand the assessment questions, including the following:
Subject cannot read and understand the instructions well enough to complete the tasks or cannot provide informed consent.
Intellectual impairment (WRAT-5 score \< 70) (at the discretion of experimenter);
Actively intoxicated, as shown via patient self-report or staff report;
Substance use disorder in the past 3 months;
Subject considered high risk for suicidal acts (i.e., active suicidal ideation as determined by clinical interview OR any suicide attempt in 30 days prior to screening);
Subject violence (involving severe/lethal means or violence occurring in prior 6 months) or extreme agitation.
Being in a current manic state
Head injury with loss of consciousness greater than 10 minutes (at the discretion of the experimenter).
Subject has had electroconvulsive therapy (ECT) in the past 8 weeks;
Diagnosed with a neurological condition (tumor, stroke, brain injury) or neurological disorder, including seizure disorders. Diagnosed with pervasive developmental disorder (phone screen or medical records)
Lazy eye or squint or other known ocular pathology
Healthy Control Subjects
Any lifetime psychotic disorder or history of psychiatric hospitalization (self disclosure);
Daily antidepressant, mood stabilizer or antipsychotic medication use in the last 6 months, or benzodiazepine use during the prior 2 days (self-disclosure); iii. First-degree relative(s) with a schizophrenia spectrum disorder (based on subject self-report) or bipolar disorder.
Case-match Control Non-ill Subjects
Any lifetime psychotic disorder (as assessed by SCID/or SSD);
Recurrent depressive episodes or being in a current depressive episode (as assessed by SCID/or SSD)
Persistent threshold psychotic symptoms
History of psychiatric hospitalization;
Daily antidepressant, mood stabilizer or antipsychotic medication use in the last 6 months, or benzodiazepine use during the prior 2 days
First-degree relative(s) with a schizophrenia spectrum disorder (based on subject self-report) or bipolar disorder.
Bipolar Subjects
Persistent threshold psychotic symptoms

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rochester?

Yes, this clinical trial (NCT06911931) has an active research site in Rochester, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Schizophrenia Disorders Treatment Options in Rochester, NY

If you're searching for schizophrenia disorders treatment options in Rochester, NY, this clinical trial (NCT06911931) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia disorders specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all schizophrenia disorders clinical trials near you to find additional studies recruiting in your area.

More Schizophrenia Trials in Rochester, NY

See all schizophrenia clinical trials recruiting in Rochester — not just this study.

Browse Schizophrenia Trials in Rochester →

Browse More Trials by Condition

Schizophrenia TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Rochester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rochester, NY